Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Unlocking the potential of cancer immunotherapy: Overcoming the challenges of 3D immune cell killing assays
unlocking-the-potential-of-cancer-1920x400
Literature - Publication Review

Unlocking the potential of cancer immunotherapy: Overcoming the challenges of 3D immune cell killing assays

3D immune cell killing assays yield more physiologically relevant results and are critical to the pursuit of more specialized therapies for the treatment of solid tumors. But they aren't without various technical and logistical difficulties. To address these challenges, this paper presents several successful assay setups that utilize various analysis technologies to study the antitumor functions of immunotherapies in a 3D environment.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Unlocking the potential of cancer immunotherapy: Overcoming the challenges of 3D immune cell killing assays

Download Literature - Publication Review
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.